-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tobemstomig in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tobemstomig in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tobemstomig in Metastatic Renal Cell Carcinoma Drug Details: RG-6139...
-
Product Insights
NewAlopecia Areata – Drugs In Development, 2024
Empower your strategies with our Alopecia Areata – Drugs In Development, 2024 report and make more profitable business decisions. Alopecia areata is an autoimmune condition characterized by unpredictable, patchy hair loss. It occurs when the immune system mistakenly attacks hair follicles, leading to hair loss in small, round patches on the scalp or other parts of the body. In some cases, it can progress to total hair loss (alopecia totalis) or loss of hair on the entire body (alopecia universalis). The...
-
Product Insights
NewAlopecia – Drugs In Development, 2024
Empower your strategies with our Alopecia – Drugs In Development, 2024 report and make more profitable business decisions. Alopecia is the partial or complete loss of hair, especially on the scalp; it can occur in patches, on the entire head, or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, exposure to irritants or toxins, burns, injuries, and infections. The Alopecia drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza [Strain A/H7N9] Vaccine in Influenza...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC) Drug Details:Adagloxad simolenin...
-
Company Profile
Netmarble Corp – Company Profile
Netmarble Corp (Netmarble) is a mobile gaming company. It carries out developing various games including Assault Gear, Blossom Party, BTS WORLD, Destiny6, Disney Magical Dice, District 187: Sin Streets, Dragon Ball Online, Dragon Striker, Everybody's Marble, Firstborn: Kingdom Come, Fishing Strike, Grandchase, GunZ: The Duel, Iron Throne, and others. The company's games are supported in android, apple, and others. It's games are used across various regions including the Americas, Europe, Asia-Pacific, Middle East, and Africa. Netmarble is headquartered in Seoul,...
Add to Basket -
Company Profile
Aristocrat Leisure Ltd – Company Profile
Aristocrat Leisure Ltd (Aristocrat) develops and distributes diversified products and services including class II and class III gaming machines and casino management systems. The company’s gaming portfolio includes RAID, Vikings, Dragon Link, Game of Thrones, Wonder 4, Dollar Storm: Buffalo Gold Revolution, Grand Star: Zorro, Timber Wolf Diamond: Cashman bingo, Choy’s Kingdom, Gold Stacks 88, The Hunt for Neptine Gold, and Lightning link. It also manufactures electronic gaming machines, social gaming and casino management systems. The company operates in online...
Add to Basket -
Company Profile
CD Projekt RED SA – Company Profile
CD Projekt RED SA (CD Projekt) is a designer, developer and publisher of role-playing video games. The product portfolio of the company includes the witcher; the witcher 2: assassins of Kings; the witcher 3: wild hunt, cyberpunk 2077, throne-breaker, the witcher tales, the witcher adventure game, went, the witcher card game. ICD Projekt also develops online multiplayer games and distributes digital video games through a wide range of online channels and digital distribution platforms directly to individual users across Russia,...
Add to Basket